Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
University of Zurich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs. Disability is largely driven by mobility deficits caused by impaired gait. Effective treatments are available to restore lower limb function and improve gait, but response to treatment varies greatly from patient to patient and ofte…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Idiopathic Parkinson's disease with gait and postural stability deficits * ≥18 years of age * United Parkinson Disease Rating Scale (UPDRS) III gait scores 1-3 * UPDRS III postural instability scores 1-3 * Prescribed rehabilitation therapy at cereneo * Informed consent as docu…
Contacts

No contact information available.